Vannan, Annika https://orcid.org/0000-0001-7796-5597
Lyu, Ruqian
Williams, Arianna L. https://orcid.org/0009-0002-2725-0221
Negretti, Nicholas M. https://orcid.org/0000-0003-1022-8650
Mee, Evan D.
Hirsh, Joseph https://orcid.org/0009-0004-0457-5503
Hirsh, Samuel https://orcid.org/0009-0009-8819-5984
Hadad, Niran
Nichols, David S.
Calvi, Carla L.
Taylor, Chase J. https://orcid.org/0000-0002-7942-0483
Polosukhin, Vasiliy. V.
Serezani, Ana P. M.
McCall, A. Scott
Gokey, Jason J.
Shim, Heejung
Ware, Lorraine B. https://orcid.org/0000-0002-9429-4702
Bacchetta, Matthew J. https://orcid.org/0000-0003-4456-4484
Shaver, Ciara M.
Blackwell, Timothy S.
Walia, Rajat https://orcid.org/0000-0001-5036-2921
Sucre, Jennifer M. S.
Kropski, Jonathan A. https://orcid.org/0000-0002-8923-1344
McCarthy, Davis J. https://orcid.org/0000-0002-2218-6833
Banovich, Nicholas E. https://orcid.org/0000-0003-2604-3247
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01HL145372, U01HL175444, HL158906, HL126176, R01HL160551, P01HL092870, U01HL175444, R01HL145372, U01HL175444)
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (R01HG011886, R01HG011886)
United States Department of Defense | United States Army | Army Medical Command | Congressionally Directed Medical Research Programs (W81XWH1910415, W81XWH1910415)
Department of Health | National Health and Medical Research Council (GNT1195595, GNT1162829)
Article History
Received: 22 January 2024
Accepted: 8 January 2025
First Online: 3 February 2025
Competing interests
: J.A.K. reports grants/contracts from Boehringer Ingelheim and Bristol Myers Squibb, stock options from APIE Therapeutics and consulting fees from ARDA Therapeutics. R.W. reports consultant fees from Genentech and Boehringer Ingelheim. T.S.B. reports grants/contracts from Boehringer Ingelheim, Bristol Myers Squibb and Morphic. The other authors declare no competing interests.